Related Experiment Video
Updated: May 20, 2026

Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
Plasmapheresis in a patient with "refractory" urticarial vasculitis
Ozgur Kartal1, Mustafa Gulec, Zafer Caliskaner
1Division of Immunology and Allergic Diseases, Gülhane Military Medical Academy and Medical School, Ankara, Turkey.
Immune complexes contribute to urticarial vasculitis. Plasmapheresis effectively removed these complexes, improving symptoms in a refractory case, suggesting its use for severe disease.
Area of Science:
- Immunology
- Dermatology
- Nephrology
Background:
- Immune complexes are implicated in urticarial vasculitis pathogenesis.
- Urticarial vasculitis affects 30%-75% of patients with circulating immune complexes.
- Limited data exists on plasmapheresis for urticarial vasculitis treatment.
Purpose of the Study:
- To report a case of refractory urticarial vasculitis successfully treated with plasmapheresis.
- To evaluate plasmapheresis as a therapeutic option for severe or treatment-resistant urticarial vasculitis.
Main Methods:
- Case report of a patient with refractory urticarial vasculitis.
- Treatment involved plasmapheresis to remove circulating immune complexes.
Main Results:
- Plasmapheresis treatment led to significant symptom improvement.
- The patient experienced remission of refractory urticarial vasculitis after the procedure.
Conclusions:
- Plasmapheresis is a viable treatment option for severe or refractory urticarial vasculitis.
- Removing immune complexes via plasmapheresis can alleviate symptoms in difficult cases.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Vascular Spasm
Hypersensitivity Reactions: Immune-Complex Reactions
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Allergic Reactions: Anaphylaxis
